Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma

BACKGROUND: The current standard of care for classical Hodgkin lymphoma (HL) is multiagent chemotherapy with or without radiation. In patients who relapse or fail to respond, additional high-dose chemotherapy with autologous hematopoietic stem cell transplantation (AHSCT) can improve progression-fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Patrick B., Pinter-Brown, Lauren C., Warsi, Ghulam, White, Kristen, Ramchandren, Radhakrishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948762/
https://www.ncbi.nlm.nih.gov/pubmed/29774169
http://dx.doi.org/10.1186/s40164-018-0103-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948762/
https://www.ncbi.nlm.nih.gov/pubmed/29774169
http://dx.doi.org/10.1186/s40164-018-0103-z

Ejemplares similares